The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation
Authors:
- Hadrien WiniszewskiHWHadrien Winiszewski
- Anne-Claire RougnyARAnne-Claire Rougny
- Jennifer Lagoutte-RenosiJLJennifer Lagoutte-Renosi
- Laurence MillonLMLaurence Millon
- Gilles CapellierGCGilles Capellier
- Jean-Christophe NavellouJNJean-Christophe Navellou
- Gael PitonGPGael Piton
- Anne-Laure ClairetACAnne-Laure Clairet
Open Access
- 22 December 2018
- journal article
- letter
- Published by Springer Nature in Critical Care
- Vol. 22 (1) , 1-3
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort studyThe Lancet Respiratory Medicine, 2018
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guidelineClinical Microbiology and Infection, 2018
- Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experimentIntensive Care Medicine, 2007